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Objective: Increased risk of prostate cancer (PCa) is observed in men with BRCA1/BRCA2
mutations. Sex and gender are key determinants of health and disease although unequal care
exists between the sexes. Stereotypical male attitudes are shown to lead to poor health outcomes.
Methods: Men with BRCA1/2 mutations and diagnosed with PCa were identified and invited
to participate in a qualitative interview study. Data were analysed using a framework approach.
“Masculinity theory” was used to report the impact of having both a BRCA1/2 mutation and PCa.
Results: Eleven of 15 eligible men were interviewed. The umbrella concept of “Ambiguity in a
Masculine World” was evident. Men's responses often matched those of women in a genetic
context. Men's BRCA experience was described, as “on the back burner” but “a bonus” enabling
familial detection and early diagnosis of PCa. Embodiment of PCa took precedence as men
revealed stereotypical “ideal” masculine responses such as stoicism and control while creating
new “masculinities” when faced with the vicissitudes of having 2 gendered conditions.
Conclusion: Health workers are urged to take a reflexive approach, void of masculine ideals, a
belief in which obfuscates men's experience. Research is required regarding men's support needs
in the name of equality of care.
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Men with BRCA1/2 mutations have an increased risk of prostate
cancer (PCa)1 with an estimated relative risk of 1.8 to 4.5 fold for
BRCA1 and 2.5 to 8.6 fold for BRCA2 mutation carriers.2,3 Numbers
of men with PCa attributed to BRCA1 or BRCA2 is relatively small but
rising (approximately 2% of men diagnosed under the age of 55).1 This
is clinically important as men with BRCA2 mutations present with
aggressive PCa at a younger age and have poor survival.4 Awareness
of PCa risk is increasing, becoming a standard part of genetic counselling
for men at risk of inheriting a BRCA1/2 mutation.- - - - - - - - - - - - - - - - - - - - - - - - - - -
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rs.Research on women with cancer predominates5 forming templates
for investigation premised on emotional expression and helplessness/
hopelessness5,6 and a need for support.7 Men are depicted in opposite
ways.5,8,9 Unequal services persist.5-12 Male studies are growing
especially in relation to PCa where psychosocial outcomes reflect stage,
treatments received, and physical status, usually sexual “dysfunction”
including impotency.13 When “masculinity” theory and a qualitative
methodology are invoked,12 masculinity is restored13-16 while, for
example, men put impotency into perspective,13,15 in terms of age, a
trade‐off for living longer, previous “sowingoats,” andwaysof compensating
for penetrative sex.13,15 Feelings of loss are, however, profound13,15;
identity, self‐esteem, coping, and adjustment issues prevail13-19
although levels of clinical psychological morbidity are low.10,13,17- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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1988 MOYNIHAN ET AL.Menwith breast cancer experience stigmatisation, embarrassment,
and altered body image, exacerbating their shock at diagnosis.20,21
Formal support programmes are lacking, information is sparse, and
deliverance gendered.20,21
Both sexes at high‐risk of BRCA1/2 are similar in their responses
regarding genetic risk.17 Both use family histories to evaluate risk and
decision‐making22,23 although women are likely to influence male
decisions.22 A lower uptake of testing and higher drop out in men12,17 is
counterbalanced by a greater interest in testing.17 Men are thought to
bemore vulnerable to psychological stress thanwomenwhen undergoing
testing17 although low levels of psychological symptoms are reported
in both sexes undergoing testing for BRCA1/2 mutations.17,24
A gender approach is invisible notwithstanding a few exceptions
where it is used as a backdrop to men's responses.12,18,19,25 No genetic
study has used “masculinity theory” as an integral aspect of research,
yet sex and gender are key determinants of health.111.1 | Masculinity theory
Psychosocial research relies on an assumption that essentialist “traits”
describe men's responses. Western societies hold to “ideal” or
“hegemonic” male characteristics such as stoicism, independence, control,
and emotional inexpressiveness,8,9,14,26-29 while women exhibit binary
opposites.8,9,26-29 The “hegemonic,” dominant formofmasculinity is always
relational—subordinating femininities and other masculinities,8,9,14-16,26-29
played out individually, and in institutions5,8,9,23-29 reinforcing expected
responses.8,9 Concern regarding the “fixed” nature of essentialism has
resulted in research that turns towards a “social constructivist” perspective
on gender or “masculinity,” the latter contingent on time and place.8,9,26,27
For example, illness may undermine men in terms of loss of control and
dependency, leading to new ways of reinstating masculinity or
“masculinities.”8,9,26-29 “Masculinity must be proved and no sooner
proved that it is again questioned and must be proved again.”27(p122)1.2 | Aims
The experiences of male BRCA1/2 carriers who have prostate cancer
are not reported. The aim of this study was to highlight men's social
characteristics to explain behaviour and attitudes where both conditions
have gendered connotations by using masculinity theory8,9,26-29 and
empirical work.10,12,13,18-22,25,30-322 | STUDY DESIGN
The Royal Marsden NHS Research Ethics Committee approved this
study. Men were identified from one UK Cancer Genetics research
clinic over 4 years (2007‐2011). The clinic managed patients known
to have a mutation in a cancer predisposition gene.
Eligibility relied on a diagnosis of PCa and a pathogenic germline
mutation in either BRCA1 or BRCA2. All patients were “counselled”
regarding their disease status. Eligible patients were invited to undergo
a semistructured interview, given an information sheet and reply slip to
express interest. Interested men were contacted, interviews arranged,
consent obtained. One‐ to two‐hour interviews were conducted in a
venue of the patients' choice. Interviews were audio recorded,transcribed, and analysed. Interviewees were at liberty to stall or
curtail interviews.
A female sociologist outside the clinical team, with relevant
experience, asked, “Has BRCAmutation status and having PCa impacted
on your life?” Topics informed by interviewees, clinical practice, and
literature were covered flexibly (Table S1).20,21
2.1 | Method of analyses
A “Framework Analysis”33 (allowing for the use of relevant topics of
interest) was used to code items at face value, followed by conceptual
coding identifying overarching themes and “deviant” accounts.33,34
Interviewing and analysis was an iterative process. Constant compari-
son was used; interpretations made by checking patients' perceptions
within and across verbatim transcripts. Interpretation relied on
context, literature, field notes, and expert opinion.33,343 | RESULTS
3.1 | Sample
Twenty‐nine participants (11 men, 9 partners, and 9 children) were
interviewed. This analysis draws on the interview data of 11 men.
Two partners were present but remained silent.
Fifteen eligible men were identified from the database; 13 men
accepted; one later declined; one was ineligible. Most men had
children (Table S2).
Participant numbers were proportional to national figures, satura-
tion achieved. Mean time between undergoing genetic testing and PCa
diagnosis was 26.5 months. Mean time between genetic testing and
study participation was 37 months. One man received his PCa diagno-
sis with advanced disease prior to mutation identification. The other
10 men had early stage disease. Nine men were diagnosed with PCa
through PSA screening, 8 of whom were screened within a research
study; 2 men were diagnosed after presenting with symptoms.
There were no discernible demographic or social differences in
responses (Table S2).
3.2 | Themes
The umbrella theme “Ambiguity in a Masculine World” wove its way
through men's responses. Four subthemes were evident. Shock at
carrier status or having PCa (Storm Clouds) was juxtaposed by the
“bonus” of early diagnoses (Silver Linings), denial and fatalism
(Brushing under Carpets) by guilt and responsibility (Facing the Music).
Vulnerability and a so‐called feminine need for “attachment” were
juxtaposed by a stereotypical “masculine” response of self‐determination,
stoicism, control, and “normality.”Nigel: “I screen for everything…I go to medical
professionals and appreciate care I get from them.....
BRCA is not my fault… a genetic accident. Could be
worse…a genetic fault (to be) a serial murderer. I was
more upset about prostate cancer…I was healthy ( ) I've
researched the prostate fanatically… cancer the enemy, I
the “General”....proactive…I am not so worried when I
MOYNIHAN ET AL. 1989know how the enemy acts…many men don't want to
know… I do, with a stoic acceptance. I might be called
‘bloody useless’ in a new relationship but I'm not a lesser
person…I am still breathing, I drink wine, new hobbies!”3.2.1 | Storm Clouds: the BRCA mutation
Participants were initially reluctant to test, claiming “low risk” (or no
risk), a “hazy” perception of hereditary transmission and the gendering
of breast cancer.21 No reference was made regarding the risk of ovarian
cancer associated with the BRCA1/2 genes. Far from being coerced to
test,17 men felt a need to pay back “work” of family members:Rupert: “My sister had breast cancer…MASSIVE in the
family……I normally wouldn't test...but she worked hard
for us…so I went, I don't go to doctors...I'm a busy
man… women get the disease and everything in
pamphlets is said towards them!”Familial images of illness and death evoked the importance of
testing in both sexes.23,24 Roger expressed shock21,22 acceptance
and pragmatism:Roger: “After the initial numbing shock (BRCA) I thought
I'd die, I wasn't surprised... being twelve... mum's in
hospital waving from her window bed…a big impact...
looking Belson like…( ) I worried…what if I've got it and
pass it on? I tested...I could tell my daughters.”While “difficulties” were downplayed, a “betwixt and between”
uncertainty29 was evident, highlighting loss of self‐esteem and disrup-
tion usually wrapped in reminders of achievement and good health
both past and present.10Jeff: “this genetic fault means imperfection…it didn't have
an illness…(I was) damaged, imperfect at a time when I
was healthy, working… had to re‐charge …having
BRCA2 was important…had I known before meeting
(wife), how would I have told someone? What if you
wanted a family?....I'm completely back to myself”A detailed account of having PCa overshadowed the telling of
what it meant to have a BRCA1/2 mutation.
3.2.2 | Storm Clouds: prostate cancer
Men with PCa focus on its physical aspects.10 Diagnosis, treatment,
and side effects loomed large in our participant's accounts. Constant
self‐referral wrapped itself around stoicism, optimism, and self‐deter-
mination.10,13-16 Distress was most profound amongst younger partic-
ipants who referred to longevity; older men described the
ramifications of treatment, any “crisis” normalised,10 all experiences
perceived to be supported by partners and hospital personnel while
containing emotions.10Jeff: “ten (biopsy) cores plus two...bleeding and had to
have a pad....I was thinking ‘death...get on with it.’.. had
the prostatectomy...impotency and incontinence didn't
matter…but I couldn't have done this without (doctor)...
she guided me, was there for me...brilliant”Martin: “My wife helped me through and through along
with the hospital staff… Incontinence was very difficult
but it is all back to normal”The “double whammy” was seldom addressed, and when it was,
prostate cancer took precedence.Edward:“I was probably more upset about prostate
cancer although I didn't show it…I've thrown the dice,
got the double whammy… get shot of it, get on with life.”
Nick: “I take the view that I would prefer to deal with
prostate cancer than any others because I've heard that
it's more likely treated successfully if caught early....”Treatment effects and fear of relapse, responses that did not
apparently warrant formal support, were stoically presented.9,10
“Counselling” might provide knowledge and advice, never to express
emotions. When emotion was articulated, it was defended:George: “After prostate cancer (PCa) surgery, I threatened
to throw myself from the window...a counsellor came…it
was nice having a chat…breaking up days…he left
realising I wasn't mad…just reacting to the situation.”3.2.3 | Silver Linings: the BRCA mutation
Shock and repercussions of the BRCA mutation were accompanied by
a sense of “bonus.” Like women, men appreciated early recognition of
BRCA as a preventative measure, not for themselves but for gaining
knowledge and scientific progress benefitting mankind, mainly
daughters.17,19,25,30-32Roger: “We are terribly lucky to have found out (about the
gene) and it offered solutions…knowledge is power…if I'd
got it…my daughter could find out too and do something”Reproductive options were seldom mentioned, although Edward,
who distanced himself from family problems, broached the subject.
His concerns counter the suggestion that emotional distancing neces-
sarily leads to downplaying risk.17Edward: “if (son) were to start a family……they would do
some in‐vitro fertilisation to check whether the gene
was present… they could selectively abort… but I asked
whether there was evidence of positive aspects of the
BRCA1 gene… (Could) you lose that if you bred it out of
the gene pool’? Answer was ‘no’!”Like affected women,12,17 men did not report clinical psychological
impairment. Men's mutation status caused distress in terms of children,
however. This is evident amongst affected women and men in other
studies.12,17,19,22,30-32Martin: “to think that our daughter might have to make a
decision! It's harder worrying that (daughter) had it rather
than myself”Men's sadness at passing on the mutation was sometimes visceral
but suppressed.
1990 MOYNIHAN ET AL.Rupert: “we love our children... in that respect one feels
responsibility...I said to (daughter)...”You've got the
wrong Daddy”....sorry I'll stop.” (crying)Despite occasional lapses into pathos and ongoing distress, men
remained optimistic “putting this BRCA stuff on the back burner.”
3.2.4 | Silver Linings: prostate cancer
The BRCA mutation led to concern for others.19,22,25,31,32 In contrast,
PCa narratives manifested highly subjective accounts.10 If PCa was
intrinsically worrying, there was a strong sense of “bonus”—care
through monitoring and early diagnosis.Richard: “I was delighted by the research ...the way we
were individually looked after…having regular checks... if
(PCa) was going to happen it would be found…multiple
bonus… This program saved me…I get on with my busy
life and keep on top of things.”Clinical psychological symptoms were absent,10,12 and formal
support seldom offered or accessed.10,13 Men showed no hesitation
in rallying health providers, seeking information, and gaining knowl-
edge.13,35 Appreciation was continuously shown for personal aspects
of supportive care received from medical personnel, the rudiments of
“attachment” emphasised.36Nick: “the doctors are brilliant…wonderful… (Nurse) was
magnificent…you can ring her up, she helps you… knows
you…just what I needed…I think (nurse) likes me…they
really looked after you.”3.2.5 | Brushing under Carpets: the BRCA mutation
Men put BRCA on the “back burner” despite the importance of
alerting family members. Few men recounted BRCA1/2 status, its
virulence never addressed, and its low risk status in men reiterated
and/or gendered. Addressing the consequences of having the
mutation was overshadowed by a PCa discourse—the embodied
disease.Jeff: “BRCA2?… it doesn't have much impact (on me)…
being male it wasn't significant… it is the prostate that
worries me.”3.2.6 | Brushing under Carpets: prostate cancer
While PCa narratives held sway,10 disclosure rarely went beyond close
family and friends.10,13,30,37 Men chose their confidants with care,
withholding details, maintaining normality, strength, and activity in
the face of shame.10,37 A reticence to “speak” out is found amongst
women in the genetic context24 and in men with PCa.37Nick: “I've always been strong… eradicate the cancer…
and get on ( )…Prostate cancer…shattering…… life goes
on…I don't speak about it...shaming...my sex life is not
as it was…it doesn't matter, I have three children!...( )
people don't want to hear...I speak to members of my
church about life and death!”“Holding back” mirrored the ways men felt about informing
children of PCa claiming that knowledge would “add to their burden.”
There was evidence, however, that men did not have the words to
say or when to say them mirroring problems in the male BRCA
arena.19,30Jeff: “how do I tell (children) and when? That's not today's
problem...( )...I haven't thought how to tell my son...”3.2.7 | Facing the Music: the BRCA mutation
Studies have shown that in contrast to men's apparent reluctance to
exchange information, and the ambiguity men display in terms of trans-
mitting genetic information to family members,17 women become the
“gatekeepers of health,”17,24,30 resulting in the “gendering of responsi-
bility.”19,30,31 In contrast, our male participants transmitted BRCA1/2
information to family including female children,17,19,24,25,32 their
fervour underpinned by guilt, and responsibility12,31 while taking on a
head of family status:Richard: “I've written letters to ALL family members...
through the BRCA gene…there is nothing in common
except this important familial relationship… I should
take on an ‘elder role’!”Fatalism sometimes overshadowed responsibility and guilt.31
Multiple genes and or a simple mutation status was argued for, as
disclosure was left to partners.Graham: “I am fatalistic, I may have many ‘genes’.... BRCA
didn't trouble me...I don't worry about things when I have
no control or discomfort...I don't have breast cancer, I
have a mutation...my wife does the telling”In a few cases, family disharmony precluded disclosure, and this is
found amongst both sexes.24,30Stephen: “I am not going to tell my 30 year old daughter
about the breast...we don't speak to each other”3.2.8 | Facing the Music: prostate cancer
Mutation status led to “facing the music” as men disclosed information
to family members while remaining silent in respect of the ways it
impinged on themselves. In contrast, subjective elements of PCa were
conveyed, syphoned through constant descriptions of activity, good
health, perspective, enabling self‐preservation.9,10,13-16,29Jeff: “(then) prostate cancer!…I thought of myself as
intelligent, good looking… girlfriends...now I've got
hobbies and work and family...I'm just as good as
before...written my first novel...live for the moment!”Negative self‐perception when evoked did not deter men from
elevating themselves by reporting “good health” and strength prior
and post diagnosis in ways that suggested perspective, activity,
control, rationality and statements of strength and “normality” all indic-
ative of the ways that men reinstated their masculine selves.10
MOYNIHAN ET AL. 1991George: “Sexual function decreased ‐ not important ‐ I am
interested in other things, fishing, motor sports...I'm
alive...(I have) incontinence from the rear and front but
there are people in wheelchairs...I thank my lucky stars
that I'm unlike them.”Restorative physical training found in other populations10,38,39
was not preferred amongst our participants. Finding new hobbies
and being proactive were indicative of the ways that men restored
“face” with optimism and fortitude.10,13Nick: “(......) I just go for it (cure for prostate cancer) I face
it!”A good relationship with the attending doctor and a need to
gather information added to an already proactive stance.7Jeff: “nerve wracking…getting (prostate) biopsy results...I
phoned (doctor) in a state…she was always there for me.
I became an expert...I was obsessed… it was my way of
dealing with it... facing the music.”4 | DISCUSSION
A qualitative methodology has enabled us to “dig deep” into how men
respond when facing two gendered conditions. By using masculinity
theory, we have revealed dynamic and ambiguous responses that are
sometimes similar to women in this context, challenging “innate”
stereotypical ways of viewing men. Men present themselves as not
only ideally masculine, but vulnerable too, sometimes simultaneously
but always in ways that reinstate masculinity.
Our participants formed a homogenous group. Caution is advo-
cated when working with diverse populations within and outside
developed countries where “hegemonic masculinity” may be perceived
in differing ways.40 Globalisation is changing the existence of gender
orders in less developed countries, often mimicking Western versions
of hegemonic masculinities.40 Where ambiguity exists, gender as a
“relational” activity, occurring in diverse locations and differing
contexts requires investigation.28,40
Men with breast cancer respond in visceral ways.20,21 Men in our
sample experienced mutation status, possibly accounting for “silence”
in the wake of an invisible disease. The gendering of breast
cancer20,21 and the lack of targeted information for men20,21 may also
have contributed to self‐confessed and relative “ignorance”
concerning that condition. Like women, however,17 and men in other
genetic studies,17,25 we found men were mindful of families'
wellbeing, especially that of daughters. Difficulties were articulated
in relation to when and how to inform children in terms of both BRCA
status and PCa.17 While men require help in that respect, reticence
was balanced by an overwhelming need to inform genetic transmission
to wider family members—countering the belief that men necessarily
exclude themselves from health matters.5,9 A “head of family” role is,
however, indicative of the ways that men reinvent themselves as
“masculine” in a context where stereotypical identities may be
undermined.10While women with BRCA1/2 mutations20,21 and men with
PCa10,17 do not generally exhibit clinical psychological symptoms, we
were surprised that men were void of severe distress in the wake of
a “double whammy,” seldom mentioned as a single entity—one that
may have been too difficult to contemplate for all its gendered conno-
tations, or because men were eager to put BRCA on a “back burner.”
Men in our sample appreciated the bonus of early PCa diagnosis and
the possibility of passing on knowledge regarding BRCA1/2. This may
have allayed significant emotional fallout17 although serious psycho-
logical symptoms are not generally an issue for men with cancer and
in larger samples than our own.10,13,17
By focusing on the treatment and aftermath of PCa, and by placing
importance on an embodied disease, we suggest that a conduit was
“produced” for normalising damaged male identities especially in the
light of carrying a BRCA1/2 mutation. As Wenger suggests, men with
PCa are challenged “to manage a fully blown cancer that disrupts an
embodied masculinity, the latter associated with action and
strength.”10 Interestingly, sexual dysfunction was rarely evoked, unlike
men in other studies,14-16 but nor was it a principle focus of our
enquiry. Reticence may have relied on early stage PCa where nerve
sparing prostatectomies preserve potency. Men did however exhibit
distress in relation to both conditions.10,13,17,18,20,21 Lives are changed,
identity issues abound, responsibility and guilt towards families is stark,
wrapped in stoicism, activity, positive self‐referral, knowledge building,
and a need and appreciation of an “attachment” to health clinicians
with whom they seemed to form a measure of equality and trust. In
contrast to this, men shunned formal support.10
Men may wish to guard vulnerability while re‐establishing some
“normality” and a sense of unscathed masculinity.10 This has to be
respected but as Wenger says men may use help seeking such as
knowledge gathering and eliciting the help of professionals10,35 “to
demonstrate power, control and even self‐reliance” as well as being
“a possible indirect request for an intervention where men's help seek-
ing is ‘socially problematic.’”10
There is an urgent need to research ways of providing support for
men where physical38,39 and/or informational resources and “good
relationships” with health personnel10,35 are addressed and where
there is a recognition of men's gendered responses such as a need to
maintain strength and identity10,38,39 as well as acknowledging
so‐called feminine responses such as expression of emotion.5,8 Men
in our sample did not display overt emotion but underneath expressed
bravado there lurked a palpable sense of sadness and fear.17
We do not believe that men (or women) necessarily experience
specific and exclusive feelings when facing difficulty. The ways in
which a man expresses distress may differ, usually to suit expectations
for all the connotations of “masculinity” that we have alluded to. These
caveats need to be cast in recognition of the pitfalls of essentialism as
they lead to unequal care.4.1 | Clinical implications
Men appear to need help regarding disclosure to children especially
boys; to understand BRCA1/2 cancer risks and inheritance patterns;
to access information and reassurance from clinicians, while being
mindful of men's need to reinstate a sense of their masculine selves.
1992 MOYNIHAN ET AL.Research is required regarding support whilst recognising the
possibility of differing needs in various populations of men. “Masculine
behaviour may mask vulnerability to reinstate male identities and
especially in the wake of bearing the “stigma” of having a so‐called
“female” mutation as well as a full blown “masculine” cancer. Health
professionals are asked to question their own gendered expectations,
the latter possibly obfuscating men's experience, rendering invisible
the “masculinities” that may be operating in this context and a need
to recognise equal care.
4.2 | Limitations
This study took place in one centre with a small homogeneous sample.
More research using gender analyses is required that includes age,
ethnicity, cultural diversity, sexuality, and socio‐economic status.
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